Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration. One-Year Findings from the IVAN Randomized Trial - Chakravarthy, U; Harding, S P; Rogers, C A; Downes, S M; Lotery, A J; Wordsworth, S; Reeves, B CThe IVAN Study Investigators (Ophthalmology, 2012)
May 10 [Epub ahead of print]